BioSpace News Archive

Biotech Beach

SpineX Demonstrates Groundbreaking Technology to Treat Children with Cerebral Palsy

SpineX, Inc., a clinical stage medtech company announced the groundbreaking results its first in human study in children with cerebral palsy.

October 5, 2022
·
3 min read
Prokarium Strengthens Patent Position Through Notice of Allowance of US Patent for Immunotherapy Prime in Combination with Cell Therapies

Prokarium Ltd, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, announced the receipt of a Notice of Allowance from the United States Patent and Trademark Office.

October 5, 2022
·
2 min read
Drug Development

Allecra Therapeutics Publishes Final Phase 3 ALLIUM Data in JAMA: Cefepime/Enmetazobactam Met Criteria for Superiority

Allecra Therapeutics announced that the final results from its Phase 3 ALLIUM trial investigating the combination of cefepime/enmetazobactam in patients with complicated urinary tract infections have been published in the Journal of the American Medical Association.

October 5, 2022
·
5 min read
Biotech Beach

Biolase Launches Research Grant Portal to Accelerate Clinical Studies on Innovative Dental Laser Technology

BIOLASE, Inc., the global leader in dental lasers, announced that it is inviting clinicians and researchers from around the world to submit research proposals via the Research Grant Portal at biolase.com/researchgrants.

October 5, 2022
·
3 min read
Business

ImmuCell Announces Preliminary, Unaudited Sales Results for Third Quarter of 2022

ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, announced preliminary, unaudited sales results for the third quarter ended September 30, 2022.

October 5, 2022
·
8 min read
InDex Pharmaceuticals to exhibit at United European Gastroenterology Week

InDex Pharmaceuticals Holding AB announced that the company will be exhibiting at the United European Gastroenterology Week October 8-11, 2022 in Vienna.

October 5, 2022
·
4 min read
Lone Star Bio

Enzolytics Reports Successful Completion of an MTD Tolerability Study of Its ITV-1 anti-HIV Therapeutic Leading to the Start of a 28-day GLP Toxicology Study

Enzolytics, Inc. announces the completion of the first phase of the animal toxicology studies on its ITV-1 anti-HIV therapeutic.

October 5, 2022
·
3 min read
TECENTRIQ® (atezolizumab) Receives CADTH Reimbursement Recommendations for the adjuvant treatment of early-stage Non-Small Lung Cell Cancer (NSCLC) and the treatment of Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Hoffmann-La Roche Limited announced that the Canadian Agency for Drugs and Technologies in Health pan-Canadian Oncology Drug Review Expert Review Committee has issued two final recommendations for TECENTRIQ®.

October 5, 2022
·
7 min read
Business

Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2022 Financial Results

Zimmer Biomet Holdings, Inc. announced its third quarter earnings conference call will be webcast on Wednesday, November 2, 2022 at 8:30 a.m. ET.

October 5, 2022
·
1 min read
Business

Nevro to Report Third Quarter 2022 Financial Results

Nevro Corp. announced that the company will report its financial results for the third quarter ended September 30, 2022 after the market closes on November 2, 2022.

October 5, 2022
·
2 min read